Literature DB >> 11685486

Further optimisation of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling.

G M Gommans1, A van Dongen, T G van der Schors, E Gommans, J F Visser, W W Clarijs, J W de Waard, J van de Bos, R O Boer.   

Abstract

The sentinel node (SLN) procedure has gained widespread acceptance for the axillary staging of patients who present with carcinoma of the breast. A first series of 21 patients were imaged 2 and 4 h after the injection of technetium-99m colloidal albumin. Preoperatively, axillary foci were located scintigraphically and with a hand-held gamma probe that was also used to detect the radiolabelled nodes 22 h later in the operating theatre. In a high percentage of our first series it was difficult to localise the sentinel node owing to a low count rate ex vivo. The aim of this study was to facilitate the detection of sentinel nodes by improving the count rate by the use of higher specific concentrations of 99mTc-colloidal albumin, with increased radiochemical labelling efficiency and stability. In vitro tests were performed to establish the radiochemical labelling efficiency and stability of different concentrations of 99-mTc-colloidal albumin. Concentrations of 2.5, 10, 20, 25, 30, 37 and 50 MBq 99mTc/microg colloidal albumin (Nanocoll) were prepared under nitrogen and in vacuum. The quality of the solutions was assessed by testing the radiochemical labelling efficiency and stability after 0.5, 2, 5, 8 and 24 h. The particle size of colloidal albumin was tested by dynamic light scattering at 30.2 degrees, 62.6 degrees and 90.0 degrees angles. Following the results of the in vitro studies, higher concentrations of 99mTc-colloidal albumin were used in vivo in a further series of 98 patients. For labelling under nitrogen, a maximum acceptable concentration of 10 MBq/microg was found, which complies with the specifications of the manufacturer. By preparing the labelling in vacuum vials, a 2.5 times greater radiochemical labelling efficiency over the entire period was achieved, and a significant improvement (P<0.002) in the in vivo series was found. It is concluded that although the rate of successful visualisation of the SLN was high in all studies, a better count rate (nine times higher) was achieved with the highest concentration of 99mTc-colloidal albumin, which facilitated the detection of the SLN by the gamma probe during surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11685486     DOI: 10.1007/s002590100590

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Methodology of 99mTc-Nanocoll sentinel node localisation in carcinoma of the breast.

Authors:  P Bourgeois; O Leduc; J P Belgrado; A Leduc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-04-19       Impact factor: 9.236

2.  Effect of increased 99mTc/99Tc ratios on count rates in sentinel node procedures: a randomised study.

Authors:  James R Ballinger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

3.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

4.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

5.  Comment on: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

Authors:  Carlo Aprile; Federica E Buroni; Lorenzo Lodola; Marco G Persico
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-26       Impact factor: 9.236

Review 6.  Systematic imaging in medicine: a comprehensive review.

Authors:  Kai Zhang; Yujie Sun; Shuang Wu; Min Zhou; Xiaohui Zhang; Rui Zhou; Tingting Zhang; Yuanxue Gao; Ting Chen; Yao Chen; Xin Yao; Yasuyoshi Watanabe; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-19       Impact factor: 9.236

7.  Optimizing the colloid particle concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer.

Authors:  Lenka Vermeeren; Sara H Muller; Willem Meinhardt; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

8.  Effect of increased (99m)Tc/(99)Tc ratios on count rates in sentinel node procedures: a randomised study.

Authors:  G M M Gommans; F M van der Zant; T G van der Schors; A van Dongen; G J J Teule; W W J Clarijs; B L A M Langenhorst; J W D de Waard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-25       Impact factor: 9.236

9.  Radioactive polymeric nanoparticles for biomedical application.

Authors:  Shentian Wu; Edward Helal-Neto; Ana Paula Dos Santos Matos; Amir Jafari; Ján Kozempel; Yuri José de Albuquerque Silva; Carolina Serrano-Larrea; Severino Alves Junior; Eduardo Ricci-Junior; Frank Alexis; Ralph Santos-Oliveira
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.